Value for Partners
SiVEC’s delivery system is extremely versatile. Partners can use the BactPac platform as a tool to build their own therapeutic pipelines for distinct disease indications using a variety of therapeutic approaches.
SiVEC seeks collaborations or partnerships from large, mid, and small biotech companies who are interested in evaluating the BactPac platform to enable the delivery of specific nucleic acid drugs (mRNA, siRNA, ASOs), polypeptide drugs (antibodies, nanobodies, proteins), or gene-editors (CRISPR, TALENS, etc.) to specific sites in the body (e.g., pancreas, lung, brain, heart).
SiVEC’s mission is to use our BactPac™ drug delivery platform to develop advanced biologics and out-license the platform to pharma companies who need a safe, tissue-targeted method of delivery to advance nucleic acid and gene therapies into clinical stages. We are developing first-in-class programs targeting cancer, infectious, and genetic diseases.